Literature DB >> 15548572

Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs. muscle cells.

Franco Capozza1, Alex W Cohen, Michelle W-C Cheung, Federica Sotgia, William Schubert, Michela Battista, Hyangkyu Lee, Philippe G Frank, Michael P Lisanti.   

Abstract

It is generally well accepted that caveolin-3 expression is muscle specific, whereas caveolin-1 and -2 are coexpressed in a variety of cell types, including adipocytes, endothelial cells, epithelial cells, and fibroblasts. Caveolin-1 and -2 are known to form functional hetero-oligomeric complexes in cells where they are coexpressed, whereas caveolin-3 forms homo-oligomeric high molecular mass complexes. Although caveolin-2 might be expected to interact in a similar manner with caveolin-3, most studies indicate that this is not the case. However, this view has recently been challenged as it has been demonstrated that caveolin-2 and -3 are coexpressed in primary cultures of cardiac myocytes, where these two proteins can be coimmunoprecipitated. Thus it remains controversial whether caveolin-2 interacts with caveolin-3. Here, we directly address the issue of caveolin isoform protein-protein interactions by means of three distinct molecular genetic approaches. First, using caveolin-1-deficient mouse embryonic fibroblasts, in which we have stably expressed caveolin-1, -2, or -3, we find that caveolin-1 interacts with caveolin-2 in this setting, whereas caveolin-3 does not, in agreement with most published observations. Next, we used a transfected L6 myoblast cell system expressing all three caveolin proteins. Surprisingly, we found that caveolin-1, -2, and -3 all coimmunoprecipitate in this cell type, suggesting that this interaction is muscle cell specific. Similar results were obtained when the skeletal muscle of caveolin-1 transgenic animals was analyzed for caveolin-1 and caveolin-3 coimmunoprecipitation. Thus we conclude that all three caveolins can interact to form a discrete hetero-oligomeric complex, but that such complex formation is clearly muscle specific.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548572     DOI: 10.1152/ajpcell.00232.2004

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  21 in total

Review 1.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

2.  Colocalization between caveolin isoforms in the intestinal smooth muscle and interstitial cells of Cajal of the Cav1(+/+) and Cav1 (-/-) mouse.

Authors:  Woo Jung Cho; Edwin E Daniel
Journal:  Histochem Cell Biol       Date:  2005-12-20       Impact factor: 4.304

Review 3.  Caveolins in cardioprotection - translatability and mechanisms.

Authors:  Jan M Schilling; David M Roth; Hemal H Patel
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

4.  Muscarinic receptor-mediated bronchoconstriction is coupled to caveolae in murine airways.

Authors:  Heike Schlenz; Wolfgang Kummer; Gitte Jositsch; Jürgen Wess; Gabriela Krasteva
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-18       Impact factor: 5.464

5.  Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition.

Authors:  Ahmed F Salem; Gloria Bonuccelli; Generoso Bevilacqua; Hwyda Arafat; Richard G Pestell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

6.  CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway.

Authors:  Casey Trimmer; Diana Whitaker-Menezes; Gloria Bonuccelli; Janet N Milliman; Kristin M Daumer; Andrew E Aplin; Richard G Pestell; Federica Sotgia; Michael P Lisanti; Franco Capozza
Journal:  Cancer Res       Date:  2010-08-13       Impact factor: 12.701

7.  Caveolin, GLUT4 and insulin receptor protein content in human arm and leg muscles.

Authors:  Hyo Sik Kim; Hyo Jeong Kim; Young Sun Kim; Sang Chul Park; Roger Harris; Chang Keun Kim
Journal:  Eur J Appl Physiol       Date:  2009-02-14       Impact factor: 3.078

8.  Lipid raft in cardiac health and disease.

Authors:  Manika Das; Dipak K Das
Journal:  Curr Cardiol Rev       Date:  2009-05

9.  A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2 diabetes: studies in a new mouse model.

Authors:  Y S Oh; L-Y Khil; K A Cho; S J Ryu; M K Ha; G J Cheon; T S Lee; J-W Yoon; H-S Jun; S C Park
Journal:  Diabetologia       Date:  2008-04-12       Impact factor: 10.122

10.  Cav1 inhibits benign skin tumor development in a two-stage carcinogenesis model by suppressing epidermal proliferation.

Authors:  Casey Trimmer; Federica Sotgia; Michael P Lisanti; Franco Capozza
Journal:  Am J Transl Res       Date:  2013-01-21       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.